Close
x
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Aug 04 2020 12:00
    37,687.91 +748.31 ( +2.03%)
  • NIFTY Aug 04 2020 12:00
    11,095.25 +203.65 ( +1.87%)
  • SENSEX Aug 04 2020 12:00
    37,687.91 +748.31 ( +2.03%)
  • NIFTY Aug 04 2020 12:00
    11,095.25 +203.65 ( +1.87%)
  • Nasdaq Aug 04 2020 04:30
    10,902.80 +157.53 ( +1.47%)
  • DJIA Aug 04 2020 04:30
    26,664.40 +236.08 ( +0.89%)
  • S&P 500 Aug 04 2020 04:30
    3,294.61 +23.49 ( +0.72%)
  • Hang Seng Aug 04 2020 02:10
    24,946.63 +488.50 ( +2.00%)
  • Crude Oil Aug 04 2020 11:03
    3,138.00 +35.00 ( +1.13%)
  • Gold Aug 04 2020 10:32
    54,560.00 +563.00 ( +1.04%)
  • Silver Aug 04 2020 11:03
    69,791.00 +4,043.00 ( +6.15%)
  • Copper Aug 04 2020 11:03
    507.65 -2.45 (-0.48%)
  • Pound / Rupee Dec 23 2016 22:30
    97.69 -0.20 (-0.21%)
  • Dollar / Rupee Dec 23 2016 22:30
    74.66 +0.04 ( +0.06%)
  • Euro / Rupee Dec 23 2016 22:30
    87.92 -0.40 (-0.45%)
  • Yen / Rupee Dec 23 2016 22:30
    0.70 -0.01 (-0.72%)

M K Proteins Ltd

BSE Code : 538420 | NSE Symbol : MKPL | ISIN:INE964W01013| SECTOR: - |

NSE BSE
 
SMC up arrow

80.60

0.00 0.00 Volume 280564

20-Jul-2020 EOD

Prev. Close

80.60

Open Price

79.00

Bid Price (QTY)

0.00(0)

Offer Price (QTY)

0.00(0)

 

Today’s High/Low 81.00 - 79.00

52 wk High/Low 81.90 - 66.50

Key Stats

MARKET CAP (RS CR) 33.62
P/E 20.77
BOOK VALUE (RS) 41.1005927
DIV (%) 0
MARKET LOT 2000
EPS (TTM) 3.88
PRICE/BOOK 1.96104227956791
DIV YIELD.(%) 0
FACE VALUE (RS) 10
DELIVERABLES (%) 87.5
4

News & Announcements

22-Jul-2020

M K Proteins Ltd - Other Announcements

22-Jul-2020

M K Proteins Ltd - M K Proteins Limited - Updates

27-May-2020

M K Proteins Ltd - Other Announcements

27-May-2020

M K Proteins Ltd - M K Proteins Limited - Trading Window

05-Sep-2019

M K Proteins AGM scheduled

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Agro Tech Foods Ltd 500215 ATFL
Akash Agro Industries Ltd 530691
Alpine Industries Ltd 519012 ALPINEIND
Ambar Protein Industries Ltd 519471
Ambik Proteins Ltd 519240
Ambuja Agro Industries Ltd 519164
Amrit Banaspati Company Ltd 531728
Anjani Solvents India Ltd 526377
Arti Agro Industries Ltd 519301
Asha Agro Industries Ltd 526309
Ashiana Agro Industries Ltd 519174
Atlas Soya Proteins Ltd 519067
AVI Industries Ltd (Wound-up) 519467
AVT Natural Products Ltd 519105 AVTNPL
Azure Exim Services Ltd 531783
Bajwa Agro Industries Ltd 530737
Basil Chemicals & Additives Ltd 532032
BCL Industries Ltd 524332
Bhakra Industries Ltd 519349
Bharani Oils Ltd 519423
Capsein Bio-Lab Ltd (Wound-up) 531730
Chakan Vegoils Ltd 519459
Chand Vanaspati Ltd 519297
Chhatar Extraction Ltd 519461
Chhattar Industries Ltd 519086
CIAN Agro Industries & Infrastructure Ltd 519477
Coromandel Agro Products and Oils Ltd 507543
Darshan Oils Ltd 526249
Diamond Agro Industries Ltd 526540
Diligent Industries Ltd 531153
Divya Jyoti Industries Ltd 526285
Dr M Soy and General Food Ltd 519512
Excel Castronics Ltd 526735
Flavex Aromats (I) Ltd 40320
G P Industries Ltd 519351
Girdharilal Sugar & Allied Industries Ltd 507506 NARMADASUG
Goa Agro Oils Ltd 519181
Gokul Agro Resources Ltd 539725 GOKULAGRO
Gokul Refoils and Solvent Ltd 532980 GOKUL
Golden Soya Ltd 519568
Growmore Solvent Ltd (Merged) 519371 GROMORSOLV
Gujarat Ambuja Exports Ltd 524226 GAEL
Gujarat Ambuja Proteins Ltd (Merged) 519061 GUJAMBPROT
Hillmens Agro (India) Ltd 40382
Ichalkaranji Soya Ltd 531315
India Castor Ltd (Wound-up) 520153
Indsoya Ltd 503639
Integrated Proteins Ltd 519606
J R Foods Ltd 530915
J S P Oils & Fats Ltd 530383
Jupiter Biotech Ltd (Merged) 524099
K S Oils Ltd 526209 KSOILS
Kabra Agro Industries Ltd 519010
Kalyani Refineries Ltd 526809
Kanel Industries Ltd 500236 KANELOIL
Kedia Continental Ltd 531445
Kemicare Products Ltd 531579
Keycer Agro Products Ltd 40443
KGN Agro Internationals Ltd 531947
KGN Enterprises Ltd 533790
Khandelwal Extractions Ltd 519064
Kocher Oil Mills Ltd 519023
Kothari Global Ltd 519176
Kriti Nutrients Ltd 533210
Kusum Agrotech Ltd 519409
Kusum Products Ltd 40689
Liberty Oil Mills Ltd 519232
M Ravji Oil Industries Ltd 519138
Mac Industries Ltd (Merged) 519220 MACIND
Madhu Refoils & Chemicals Ltd 524338
Madhumilan Syntex Ltd 514230 MADHUSYNTX
Madhyavart Exxoil Ltd 526287
Maheshwari Proteins Ltd 507682
Makan Agro Oils Ltd 519246
Mangalam Global Enterprise Ltd 535349 MGEL
Mangalwedhe Sun-Soya Ltd 523834
Manorama Industries Ltd 541974
Mansinghka Oil Products Ltd 519189
Midland Industries Ltd 509083
Modi Naturals Ltd 519003
Murli Industries Ltd 519323 MURLIIND
N K Industries Ltd 519494 NKIND
Natraj Proteins Ltd 530119
Natural Biocon (India) Ltd 543207
Navcom Industries Ltd 519200
Nu Tech Organic Chemicals Ltd 531075
Nu-Tech Agros Ltd 519337
Organic Chemoils Ltd 524107
Pan Asia Global Ltd 519325 PANASIGLOB
Pankaj Agro Protinex Ltd 519194
Paos Industries Ltd 530291
Pawan Proteins Ltd 519445
Poona Dal and Oil Industries Ltd 519359
Prakash Solvent Extractions Ltd 519430
Premier Industries (India) Ltd 507831
Premier Proteins Ltd 519178
Prestige Foods Ltd(Merged) 519027
Prima Industries Ltd 531246
Prime Solvent Extractions Ltd 519447
Progrex Ventures Ltd 531265
Prudential Sri Jagannath Agro-Tech Ltd 519289
R L Agrotech Ltd 519333
Raghunath Cotton & Oil Products Ltd 519258
Raj Oil Mills Ltd 533093 RAJOIL
Rajesh Solvex Ltd 519514
Rasoya Proteins Ltd 531522 RASOYPR
Ratnamani Agro Industries Ltd 507652
Richirich Inventures Ltd 519230
Rico Agroils Ltd (Merged) 519196
Rishi Oil & Fats Ltd (Wound-up) 526317
ROM Industries Ltd (Liquidated) 519166 ROMIND
Ruchi Soya Industries Ltd 500368 RUCHI
S & S Industries & Enterprises Ltd 523554 S&SIND
Sagar Soya Products Ltd 507663
Sakthi Soyas Ltd (Merged) 519146
Sanjivani Agro Industries Ltd 519405
Sarda Proteins Ltd 519242
Sarvottam Industries Ltd 519315
Satguru Agro Industries Ltd 519192
Sathyakamal Agros Ltd 530761
Sharda Solvent Ltd 530679
Shetkari Solvent (India) Ltd 40166
Shree Rajivlochan Oil Extraction Ltd 530295
Shree Ram Protiens Ltd 532567 SRPL
Shree Shakthi Agro Oils Ltd 519449
Shri Anjaney Agro Foods Ltd 519489
Shri Ishar Agro Ltd(wound-up) 519355
Shri Sainath Proteins Ltd 531701
Sidh Industries Ltd 526979
SKG Solvex Ltd 524240
South East Agro Industries Ltd 531679
Spisys Ltd 539168
SUL India Ltd 507517
Suncity Industries Ltd 519610
Sunrise Oleochemicals Ltd(liquidated) 530935
Superior Industrial Enterprises Ltd 519234
Suraj Industries Ltd 526211
Surya Agroils Ltd(wound-up) 500406 SURYAGROIL
Thapar Agro Mills Ltd 519029 THAPARAGRO
Thapar Oils & Fats Ltd 519443
Tinna Oils & Chemicals Ltd 519256
Tirupati Industries (India) Ltd 531547
Trezer Oil Agro Tech Ltd 531170
Tri-Star Soya Products Ltd(wound-up) 507668
Trombo Extractions Ltd 519303
Unique Agro Processors (India) Ltd 526915
United Soyaa Products Ltd 519001
Varuna Agroproteins Ltd 519144
Vegepro Foods & Feeds Ltd 519140 VEGPROFOOD
Vijay Solvex Ltd 531069
Vimal Oil and Foods Ltd 519373 VIMALOIL
Vippy Industries Ltd 519039 VIPPYSOLVX
Vizar Agrochemicals Ltd 531567
Vrundavan Agro Industries Ltd 519542
Yuvraj International Ltd 512285

Share Holding

Category No. of shares Percentage
Total Foreign 0 0.00
Total Institutions 0 0.00
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 786000 18.85
Total Promoters 3120800 74.83
Total Public & others 264000 6.33
Total 4170800 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About M K Proteins Ltd

MK Proteins Limited was incorporated in Haryana, as ' MK Proteins Private Limited', under the provision of the companies Act 1956, vide certificate of incorporation dated June 15, 2012. Subsequently, the company was converted into Public Limited Company, and the name of the company was changed to 'MK Proteins Limited', pursuant to shareholders resolution dated January 20, 2017, vide fresh certificate of incorporation dated February 8, 2017, issued by Registrar of Companies. The company is engaged in the business of manufacturing and trading of Edible Oils, having its production/refining plant of Edible Oils. The companies manufacturing process also involves refining of crude oils to obtain Refined Rice Bran Oil, Canola Oil, Soya Bean Oil, Sunflower Oil and Rice Bran Bleached Oil. During the refining processes, the company also manufactures Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums and spent earth, which are also saleable. Further, the company also imports crude oils, process and sells it. The company also trades in both edible and non-edible oils. In the year 2012, the company has taken on lease, land and building from the place of its operation i.e's currently from Shib Charan Dass Industries Private Limited, the group company. Simultaneously the company has also acquired its old plant, machinery and other equipments for manufacturing of Vegetable Refined Oil for Rs.290.61 Lakhs, which has an installed capacity of 120 TPD for manufacturing/refining of Vegetable Refined Oil. In the year 2014-15, the company has still expanded its manufacturing capacity from 120 TPD to 250 TPD by investing a sum of Rs.383.31 Lakhs, towards Plant and Machinery, Boiler, and Generator Set, which came into commercial production with effect from September 26, 2014. The company has also entered into a Consignment Agreement dated January 20, 2014, with Shivalik Steels and Alloys Private Limited, with the companies group company also granting an exclusive right to sell the goods in Himachal Pradesh and Punjab on commission basis. The company is focused at production of highest quality of edible oil. The company refinery is completely mechanised and now they produce Rice bran oil, Sunflower oil etc., with protein content and also controlled fiber free from oil residue, ash, sand and silica. This is possible only through sustained levels of cleaning, storage and monitoring arrangements.

M K Proteins Ltd Chairman Speech

M K Proteins Ltd Company History

MK Proteins Limited was incorporated in Haryana, as ' MK Proteins Private Limited', under the provision of the companies Act 1956, vide certificate of incorporation dated June 15, 2012. Subsequently, the company was converted into Public Limited Company, and the name of the company was changed to 'MK Proteins Limited', pursuant to shareholders resolution dated January 20, 2017, vide fresh certificate of incorporation dated February 8, 2017, issued by Registrar of Companies. The company is engaged in the business of manufacturing and trading of Edible Oils, having its production/refining plant of Edible Oils. The companies manufacturing process also involves refining of crude oils to obtain Refined Rice Bran Oil, Canola Oil, Soya Bean Oil, Sunflower Oil and Rice Bran Bleached Oil. During the refining processes, the company also manufactures Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums and spent earth, which are also saleable. Further, the company also imports crude oils, process and sells it. The company also trades in both edible and non-edible oils. In the year 2012, the company has taken on lease, land and building from the place of its operation i.e's currently from Shib Charan Dass Industries Private Limited, the group company. Simultaneously the company has also acquired its old plant, machinery and other equipments for manufacturing of Vegetable Refined Oil for Rs.290.61 Lakhs, which has an installed capacity of 120 TPD for manufacturing/refining of Vegetable Refined Oil. In the year 2014-15, the company has still expanded its manufacturing capacity from 120 TPD to 250 TPD by investing a sum of Rs.383.31 Lakhs, towards Plant and Machinery, Boiler, and Generator Set, which came into commercial production with effect from September 26, 2014. The company has also entered into a Consignment Agreement dated January 20, 2014, with Shivalik Steels and Alloys Private Limited, with the companies group company also granting an exclusive right to sell the goods in Himachal Pradesh and Punjab on commission basis. The company is focused at production of highest quality of edible oil. The company refinery is completely mechanised and now they produce Rice bran oil, Sunflower oil etc., with protein content and also controlled fiber free from oil residue, ash, sand and silica. This is possible only through sustained levels of cleaning, storage and monitoring arrangements.

M K Proteins Ltd Directors Reports

To The Members,

Your directors have pleasure in presenting the 7th Annual Report together with the Audited Statements of Accounts of the Company for the financial year ended 31st March, 2019:

1. Financial Highlights:

(In Lacs)
2018-19 2017-18
Revenue from Operations 15677.30 17164.36
Operating Expenditure 15180.00 16612.86
Other Income (Net) 7.26 5.59
Earning before interest tax, depreciation and amortization (EBITDA) 504.56 557.09
Finance Costs 153.70 214.32
Depreciation and amortization expenses 122.35 122.42
Profit before exceptional item and tax 228.51 220.35
Exceptional item 0.00 0.00
Profit Before Tax (PBT) 228.51 220.35
Tax Expenses 64.19 77.69
Profit After Tax (PAT) 164.32 142.66
Add: Balance Brought forward from previous year 297.46 154.76
Less: Income Tax for earlier years adjusted 0.00 (0.04)
Amount of Surplus available for appropriation 461.78 297.46

2. Operations, State of Company s affairs and Future Outlook:

Our Company is a manufacturing and trading organization having its production/refining plant of Edible Oils. Our manufacturing process involves refining of Crude Oils to obtain Refined Rice Bran Oil, Canola Oil, Soya Bean Oil, Sunflower Oil and Rice Bran Bleached Oil. During the refining process certain by-products are also manufactured such as Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums and Spent Earth which are also saleable. Further, it also imports crude oils, process them and sell the finished product and trade in both edible and non-edible oils. In the current year 2018-19, the Company has earned the total revenue from operation Rs.15677.30 Lacs against the previous year Rs.17164.36, which reflects the fall of 8.66% due to overall recession in the market. However, the net profit after tax of the company is increased from Rs.220.35 Lacs to Rs.228.51 Lacs in the year 2018-19. The management of the Company expect better results in the ensuing year because the product of the Company has demand since, its nature of human consumption in the ensuing financial year and years to come. We further inform that there is no change in the business activities of the company in the current financial year.

3. Dividend:

No dividend has been recommended by the Directors this year and consequently no amounts have been transferred to general reserves.

4. Transfer to Reserves:

The board of the Company has decided not to transfer any fund to general reserve out of the amount available for appropriation and an amount of surplus Rs.461.78 Lacs to be retained in the profit and loss account.

5. Change in Share Capital, if any

There has been no change in Share Capital of the Company during the financial year 2018-19.

6. Listing of Shares

The shares of the Company are listed on the Emerge SME Platform of the National Stock Exchange of India Limited w.e.f. 18 April, 2017. Applicable listing fees have been paid up to date. The shares of the Company have not been suspended from trading at any time during the year by the concerned Stock Exchange.

7. Deposits:

The company has not accepted any deposits from the public during the year and as such, no amount on account of principal or interest on deposits from public was outstanding as on the date of the balance sheet.

8. Directors:

As per the provisions of Section 152 of the Companies Act, 2013, Sh. Parmod Kumar, Director of the Company retires by rotation at the forthcoming Annual General Meeting and being eligible, offered himself for re-appointment. The Board recommends his re-appointment.

The notice convening the Annual General Meeting includes the proposal for appointment of Director.

Further, your Company has also received declarations from all the Independent Directors of the Company confirming that they meet with the criteria of Independence as prescribed under the Act and as per Listing Agreement with the Stock Exchanges.

9. Board Evaluation:

Pursuant to the provisions of the Companies Act, 2013 and Clause 49 of the Listing Agreement, the Board has carried out the annual performance evaluation of its own performance, the Directors individually as well as the valuation of the working of its various committees as per the criteria of evaluation provided in the Nomination, Remuneration and Evaluation Policy adopted by the Company. The performance evaluation of Independent Directors was carried out by the entire Board and the performance evaluation of the Chairman and the Board as a whole was carried out by the Independent Directors.

10. Meetings of the Board:

The Board of Directors of your company met 8 times during 2018-19. The meetings were held on 12/04/2018, 08/05/2018, 30/05/2018, 06/07/2018, 28/08/2018, 14/11/2018, 23/01/2019 and 30/03/2019. The intervening gap between the meetings was within the period prescribed under the Companies Act, 2013.

11. Particulars of Loan given, Investment made, Guarantee given and Securities provided:

There were no loans given, investment made, guarantee given and securities provided by the Company under Section 186 of the Companies Act, 2013 during the year under review and hence the said provision is not applicable.

12. Extract of Annual Return:

As provided under Section 92(3) of the Act, the extract of annual return is given in Annexure I in the prescribed Form MGT-9, which forms part of this report.

13. Subsidiary, Joint Ventures and Associate Concerns:

The Company does not have any Subsidiary, Joint Ventures or Associate Concerns as on 31st March, 2019.

14. Corporate Governance:

The Company has been exempt from reporting on Corporate Governance as per Regulation 15 of the SEBI (Listing Obligation and Disclosure requirements) Regulation 2015. Therefore, Corporate Governance Report is not provided.

15. Management s Discussion and Analysis Report

Management s Discussion and Analysis Report for the year under review, as stipulated under SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015, as applicable, is presented in a separate section forming part of the Annual Report.

16. Directors Responsibility Statement:

In accordance with the provisions of Section 134(5) of the Companies Act, 2013, the directors hereby confirm that:

i) in the preparation of the annual accounts for the financial year ended 31st March, 2019, the applicable accounting standard have been followed and there are no material departures;

ii) they have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31st March 2019 and of the profit of the Company for the period from 1st April 2018 to 31st March 2019;

iii) they have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013, for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;

iv) they have prepared the annual accounts on a going concern basis;

v) they have laid down internal financial controls to be followed by the Company and such internal financial controls are adequate and operating effectively; and

vi) they have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

17. Contract and arrangements with Related Parties:

The Company s policy on dealing with related party transactions has been formulated and amended from time to time. All contracts/arrangements/ transactions entered by the Company during the financial year with related parties were in the ordinary course of business and on the arm s length basis. There are no materially significant related party transactions made by the company with promoters, directors, key managerial personnel or other designated persons, which may have a potential conflict with the interest of the company at large. Your Directors draw attention of the members to Note 29(f) to the financial statements which set out related party disclosures pursuant to listing agreement. Information on transactions with related parties pursuant to Section 134(3)(h) of the Act read with rule 8(2) of the Companies (Accounts) Rules, 2014 are given in Annexure II in Form AOC-2 and the same forms part of this report.

18. Auditor and Auditors Report:

M/s Jayant Bansal & Co., Chartered Accountants, Ambala Cantt, Statutory Auditors of the company, holds office till the conclusion of the ensuing Annual General Meeting and are eligible for appointment and approval of their appointment for the financial years ending 31st March, 2020 to 31st March, 2022.

M/s Jayant Bansal & Co., Chartered Accountants, Ambala Cantt, who were appointed as Statutory Auditors for a period of 4 years from 31st March, 2016 to 31st March 2019 being eligible for appointment and approval at this Annual General Meeting have agreed to act Statutory Auditors to the Company for the financial years ending 31st March, 2020 to 31st March, 2022.

As required under the provisions of section 139(1) of the Companies Act, 2013, the company has received a written consent from M/s Jayant Bansal & Co., Chartered Accountant to their appointment and a certificate, to the effect that their re-appointment, if made, would be in accordance with the Act and the Rules framed there under and that they satisfy the criteria provided in section- 141 of Companies Act, 2013. The Board recommends their appointment for the financial years ending 31st March, 2020 to 31st March, 2022.

The report of Statutory Auditors (appearing elsewhere in this Annual Report) is self-explanatory having no adverse comments. There were no instances of fraud reported by the Statutory Auditors to the Central Government or to the Audit Committee of the Company as indicated under the provisions of Section 143(12) of the Companies Act 2013.

Further auditor s report for the financial year ended 31st March, 2019 is given as an annexure which forms part of this report.

19. Secretarial Auditors:

Pursuant to provisions of Section 204 of the Companies Act, 2013 and the Companies (Appointment and Remuneration of Managerial Personnel) Rules 2014, the Company has appointed M/s J. P. Jagdev & Co., Ambala City, a firm of Company Secretaries in practice to conduct Secretarial Audit for the financial year 2018-19. The Secretarial Audit Report for the financial year ended 31st March, 2019 is annexed herewith as Annexure III to this Report. The Secretarial Audit Report does not contain any qualification, reservation or adverse remark.

20. Corporate Social Responsibility (CSR):

The Company is not required to constitute a Corporate Social Responsibility Committee as it does not fall within purview of Section 135(1) of the Companies Act, 2013 and hence it is not required to formulate policy on corporate social responsibility.

21. Risk Management:

The board of the Company has formed a risk management committee, to frame, implement and monitor the risk management plan for the Company. The Committee is responsible for reviewing the risk management plan and ensuring its effectiveness. The audit committee has additional oversight in the area of financial risks and controls. Major risks identified by the businesses and functions are systematically addressed through mitigating actions on a continuing basis.

22. Internal Control System and their adequacy:

The Company s internal controls are commensurate with the size of the company and the nature of its business. These have been designed to provide reasonable assurance with regard to recording and providing reliable financial and operational information, complying with applicable statutes, safeguarding assets from unauthorized use, executing transactions with proper authorization and ensuring compliance of corporate policies. The company has an audit committee, the details of which are provided in the Corporate Governance Report. The audit committee reviews the internal control system and follows up on the implementation of corrective actions, if required. The committee also meets the company s statutory auditors to ascertain, interalia their views on the adequacy of internal control system in the Company and keeps the Board of Directors informed of its major observations from time to time. The management also regularly reviews the utilization of fiscal resource, compliance with law, efficiencies, so as to ensure optimum utilization of resources and achieve better efficiencies. Based on its evaluation (as defined in section 177 of Companies Act 2013), our audit committee has concluded that, as of March 31, 2019, our internal financial controls were adequate and operating effectively.

23. Vigil Mechanism Policy:

The Company has a vigil mechanism policy which also incorporates a whistle blower policy in line with the provisions of the Section 177(9) and (10) of the Companies Act, 2013 and regulation 22 of the Listing Regulations, which deals with the genuine concerns about unethical behaviour, actual or suspected fraud and violation of the Company s Code of Conduct and ethics.

24. Committees of Board:

The Board of Directors of your Company had already constituted various committees in compliance with the provisions of the Companies Act, 2013 and Listing Agreement viz. Audit Committee, Nomination and Remuneration Committee and Shareholder s/Investor s Relationship Committee. All decisions pertaining to the constitution of committees, appointment of members and fixing the terms of reference / role of the Committees are taken by the Board of Directors. Detail of the role and composition of Committees, including the number of meetings held during the financial year and attendance at meetings, are provided in annexure - IV, which forms part of this report.

25. Conservation of Energy, Technology absorption and foreign exchange earning and outgo:

Information required under Section 134(3) (m) of Companies Act, 2013 read with Companies (Accounts) Rules, 2014 is given as under:

(A) Conservation of energy:

(i) The steps taken or impact on conservation of energy:

The Company is using Government supply of electricity and own generation by its generators.

(ii) The steps taken by the company for utilizing alternate sources of energy:

There are no alternate sources of energy with the Company.

(iii) The capital investment on energy conservation equipments: Investment on energy conservation equipments is made wherever it is possible mostly it is NIL.

(B) Technology absorption:

(i) The efforts made towards technology absorption:

Plant and machinery are indigenous and no machinery and technology has been imported by the Company

(ii) The benefits derived like product improvement, cost reduction, product development or import substitution:

Indigenous machinery is state of Art and the company derives benefits on cost reduction of production.

(iii) In case of imported technology (imported during the last three years reckoned from the beginning of the financial year)- :

No technology has been imported by the Company.

(iv) The expenditure incurred on Research and Development: No specific expenditure is incurred on Research and Development.

(C) Foreign exchange earnings and Outgo:

The Company s main line of business is processing of vegetable edible oils. The Company has achieved Export Turnover of Rs. Nil during the year under report 2018-19, as compared to Rs. Nil in the previous year 2017-18. However, the Company has incurred expenditure in foreign currency for import of material. The details of the same are given below: -

(Rs. in Lacs)
Particulars 2018-19 2017-18
Total Foreign Exchange Received (F.O.B. Value of Export) NIL NIL
Total Foreign Exchange used:
i) Raw Materials & Consumable Stores NIL 60066006.48
ii) Capital Goods NIL NIL
iii) Foreign Travels NIL NIL
iv) Others (Traded Goods) NIL NIL

26. Nomination, Remuneration and Evaluation Policy:

The Nomination, Remuneration and Evaluation Policy recommended by the Nomination and Remuneration Committee is duly approved by the Board of Directors of the Company and the same are provided in annexure IV, which forms part of this report.

27. Human Resources:

Your Company treats its human resources as one of its most important assets and has taken continuous efforts to set up and maintain an efficient work force. The company is continuously taken steps towards maintaining a low attrition rate which it believes shall be achieved by investing in learning and development programmes for employees, competitive compensation, creating a compelling work environment, empowering employees at all levels as well as a well-structured reward and recognition mechanism.

28. Particulars of Employees:

I) The information required under Section 197 of the Act read with rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are given below:

a. The ratio of the remuneration of each director to the median remuneration of the employees of the Company for the financial year:

Executive Director Ratio to median Remuneration
1 Sh. Vinod Kumar (Managing Director) 0.20:1
2. Sh. Raj Kumar (Whole Time Executive Director) 0.20:1

Note: The Company has not given any remuneration/benefits to non-executive/independent directors of the company during the year 2018-19 except directors sitting fee Rs.250000.000 to Non-executive Independent directors.

b. The percentage increase in remuneration of each director, chief executive officer, chief financial officer, company secretary in the financial year:

Directors, Company Secretary and Financial Officer % increase in remuneration in the financial year
1 Sh. Vinod Kumar (Managing Director) NIL
2. Sh. Raj Kumar (Whole Time Executive Director) NIL
3. Ms. Vipinjeet Kaur (Company Secretary) NIL
4. Sh. Nipun Garg (Financial Officer) NIL

c. The percentage increase in the median remuneration of employees in the financial year: 2.5%

d. The number of permanent employees on the rolls of Company: 34 Employees as on 31st March, 2019.

e. The explanation on the relationship between average increase in remuneration and

Company performance: The performance of the Company for the current financial year is better than the previous year. The Company has minor increase in remuneration to Executive Director/key managerial personnel. However, at Middle & Junior level management, the proper increment was given in accordance with the inflation rate and at workmen and staff level.

f. Comparison of the remuneration of the key managerial personnel against the performance of the Company:

Remuneration to Managing and Whole Time directors were paid as per the scale approved by the members of the company. The head (Corporate Finance) was promoted to the position of Financial Officer, hence he was given an increase as a part of promotion and salary adjustment.

g. Variations in the market capitalization of the Company, price earnings ratio as at the closing date of the current financial year and previous financial year:

Particulars March 31, 2019 March 31, 2018 % Change
Market Capitalization (Rs. In Lacs) 3330.38 -6.70

h. Percentage increase over decrease in the market quotations of the shares of the Company in comparison to the rate at which the Company came out with the Last public offer:

Particulars March 31, 2019 March 31, 2018 % Change
Market Price (NSE) (Average Price) 79.85 (Average Price) -7.89

i. Average percentile increase already made in the salaries of employees other than the managerial personnel in the last financial year and its comparison with the percentile increase in the managerial remuneration and justification thereof and point out if there are any exceptional circumstances for increase in the managerial remuneration: Proper increments at both managerial and staff/worker level has been given in financial year 2018-19.

j. Comparison of each remuneration of the key managerial personnel against the performance of the Company: The head (Corporate Finance) was promoted to the position of Financial Officer, hence he was given an increase as a part of promotion and salary adjustment.

k. The key parameters for any variable component of remuneration availed by the directors: No such variable component is included in the remuneration paid to directors.

l. The ratio of the remuneration of the highest paid director to that of the employees who are not directors but receive remuneration in excess of the highest paid director during the year: Sh. Raj Kumar (Whole Time Director): 0.20:1

m. Affirmation that the remuneration is as per the remuneration policy of the Company: The Company affirms remuneration is as per the remuneration policy of the Company.

II. There was no employee on the roll of the company who drew remuneration in excess of the limits prescribed by the provisions of Section 197(12) of the Companies Act, 2013 read with Rules 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, hence this relevant information is not applicable to the Company.

29. Disclosure under sexual harassment of women at workplace (Prevention, Prohibition & Redressal) Act, 2013:

The company has complied with provisions relating to the constitution of Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 (114) of 2013.

30. CFO Certification:

In compliance with Regulation 17(8) of the Listing Regulations, a declaration by CFO was placed before the Board, certifying the accuracy of Financial Statements and the adequacy of internal controls pertaining to Financial Reporting for the year ended 31st March, 2019 is attached herewith as per Annexure - V.

31. Auditors Certificate on Corporate Governance:

As per Regulation 15 of the SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015, the compliance with the Corporate Governance provisions shall not apply in respect of (a) listed entity having paid up equity share capital not exceeding ten crore and net worth not exceeding rupees twenty five crore as on the last day of previous year (b) the listed entity which has listed its specified securities on the SME Exchange. Hence, Auditors Certificate on Corporate Governance is not provided.

32. Code of Conduct::

The Board of Directors has an important role in ensuring good Corporate Governance and has laid down the Code of Conduct for Directors and Senior Management of the Company. The Code has also been posted on the website of the Company. All Directors and Senior Management personnel have affirmed the compliance thereof for the year ended March 31, 2019.

Declaration

I hereby declare that pursuant to Schedule V (Part D) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company have adopted a Code of Conduct for the Board members and Senior Management of the Company and the same has also been posted in the Company s website and that all the Board members and Senior Management personnel to whom this Code of Conduct is applicable have affirmed the compliance of the said Code of Conduct during the year 2018-19.

Ambala Vinod Kumar
27th August, 2019 (Managing Director)

33. Other Disclosures:

Your Directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these items during the year under review:

i) No significant or material orders were passed by the Regulators or Courts or Tribunals which impact the going concern status and Company s operations in future.

ii) No Material changes and commitments affecting the financial position of the Company occurred between the end of the financial year to which these financial statements relate and the date of this Report.

2. The provisions of Section 125(2) of the Companies Act, 2013 related with transfer of unclaimed dividend to Investor Education and Protection Fund do not apply to the Company as there was no dividend declared and paid in previous years and there is no unclaimed dividend.

3. Equity Shares:

No issue of equity shares with differential rights as to dividend, voting or otherwise during the year under review. The Company has not bought back any of its securities during the year under review. No issue of shares (including sweat equity shares) to employees of the Company under Stock option Scheme during the year under review. No Shares outstanding under the head Shares Suspense Account/Unclaimed Suspense Account at the beginning and end of the year under review.

34. Acknowledgements:

Your directors wish to place on record their gratitude for the valued support and assistance extended to the Company by the Shareholders, Banks and Government Authorities and look forward to their continued support. Your directors also express their appreciation for the dedicated and sincere services rendered by the Executives, Officers and Employees of the Company.

By Order of the Board of Directors
Place: Ambala
Dated: 27-08-2019
(VINOD KUMAR)
Managing Director
DIN: 00150507

   

M K Proteins Ltd Company Background

Vinod Kumar
Incorporation Year2012
Registered OfficeNaraingarh Road,Village Garnala
Ambala,Haryana-134003
Telephone91-171-2679157/2679358,Managing Director
Fax
Company SecretaryPrerna Mehta
AuditorJayant Bansal & Co
Face Value10
Market Lot2000
ListingNSE - SME,
RegistrarBigshare Services Pvt Ltd
E-2/3 Ansa Indl Est,Saki Vihar Road ,Sakinaka Andheri(E) ,Mumbai - 400072

M K Proteins Ltd Company Management

Director NameDirector DesignationYear
Vinod KumarManaging Director2019
Raj KumarWhole-time Director2019
Parvind KumarDirector2019
Pramod KumarDirector2019
Chatter SinghIndependent Director2019
Raman Kumar SahIndependent Director2019
Abhay KumarIndependent Director2019
Dinesh Singh MalikIndependent Director2019
Laxmi MandalIndependent Director2019
Prerna MehtaCompany Secretary2019

M K Proteins Ltd Listing Information

M K Proteins Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
Revenue from operations NA 000155.56015

Contact us